TB

The Tuberculosis Drug Information Guide, 2nd edition, is derived from Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (2nd edition) produced in 2008. Two additional drugs, ofloxacin and clarithromycin (which are used primarily outside of the US), have been included. This Guide can help any physician, nurse, or pharmacist who participates in the management of patients with TB or LTBI.

This interim guidance provides advice on the inclusion of bedaquiline in the combination therapy of MDR-TB in accordance with the existing WHO Guidelines for the Programmatic Management of Drug-resistant TB (2011 Update).

This fact sheet provides basic information about TB.

This document sets out basic principles for prioritizing risk groups and choosing a screening approach. It emphasizes the importance of assessing the epidemiological situation, adapting approaches to local situations, integrating TB screening into other health-promotion activities, minimizing the risk of harm to individuals, and engaging in continual monitoring and evaluation.

A 2-hour webinar focuses on tools and strategies State and local health departments can use to help private providers (including Federally Qualified Health Centers, Community Health Clinics, HMOs, and smaller practice practitioners) get up-to-speed on the diagnosis and treatment of latent TB infection (LTBI).

This video provides explanations for the correct production of sputum for the diagnosis of TB.

A 2-hour webinar covers some common questions around LTBI treatment that may not be addressed in national guidelines, but represent a sample of everyday challenges shared by providers of LTBI care.

A 90-minute webinar about the basics of reading radiographs to diagnose TB disease. Intended for physicians and nurses who diagnose TB.

This video provides information on MDR-TB.

This fact sheet describes Mycobacterium bovis (bovine tuberculosis) in humans. It is also available in Spanish.